Skip to main navigation Skip to search Skip to main content

Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial.

  • Michael Gnant
  • , Brigitte Mlineritsch
  • , Herbert Stoeger
  • , Gero Luschin-Ebengreuth
  • , Dietmar Heck
  • , Christian Menzel
  • , Raimund Jakesz
  • , Michael Seifert
  • , Michael Hubalek
  • , Gunda Pristauz
  • , Thomas Bauernhofer
  • , Holger Eidtmann
  • , Wolfgang Eiermann
  • , Guenther Steger
  • , Werner Kwasny
  • , Peter Dubsky
  • , Gerhard Hochreiner
  • , Ernst-Pius Forsthuber
  • , Christian Fesl
  • , Richard Greil (Last author)

Research output: Contribution to journal › Original Article › peer-review

393 Citations (Web of Science)
Original languageEnglish
Pages (from-to)63-41
JournalLANCET ONCOL
Volume12
Issue number7
DOIs
Publication statusPublished - 2011

Keywords

  • POSTMENOPAUSAL WOMEN
  • ANTITUMOR-ACTIVITY
  • OVARIAN ABLATION
  • AUSTRIAN BREAST
  • ORAL CLODRONATE
  • TUMOR-CELLS
  • ZO-FAST
  • BISPHOSPHONATES
  • SURVIVAL
  • CHEMOTHERAPY

Cite this